These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18024510)

  • 1. Efavirenz accelerates HIV-1 reverse transcriptase ribonuclease H cleavage, leading to diminished zidovudine excision.
    Radzio J; Sluis-Cremer N
    Mol Pharmacol; 2008 Feb; 73(2):601-6. PubMed ID: 18024510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.
    Álvarez M; Nevot M; Mendieta J; Martínez MA; Menéndez-Arias L
    J Biol Chem; 2018 Feb; 293(7):2247-2259. PubMed ID: 29275329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3'-azido-3'-deoxythymidine through both RNase H-dependent and -independent mechanisms.
    Ehteshami M; Beilhartz GL; Scarth BJ; Tchesnokov EP; McCormick S; Wynhoven B; Harrigan PR; Götte M
    J Biol Chem; 2008 Aug; 283(32):22222-32. PubMed ID: 18547911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.
    Brehm JH; Scott Y; Koontz DL; Perry S; Hammer S; Katzenstein D; Mellors JW; Sluis-Cremer N;
    PLoS One; 2012; 7(2):e31558. PubMed ID: 22363673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors.
    Schneider A; Corona A; Spöring I; Jordan M; Buchholz B; Maccioni E; Di Santo R; Bodem J; Tramontano E; Wöhrl BM
    Nucleic Acids Res; 2016 Mar; 44(5):2310-22. PubMed ID: 26850643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which the G333D mutation in human immunodeficiency virus type 1 Reverse transcriptase facilitates dual resistance to zidovudine and lamivudine.
    Zelina S; Sheen CW; Radzio J; Mellors JW; Sluis-Cremer N
    Antimicrob Agents Chemother; 2008 Jan; 52(1):157-63. PubMed ID: 17967907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of HIV-1 resistance to 3'-azido-2',3'-dideoxyguanosine.
    Meteer JD; Schinazi RF; Mellors JW; Sluis-Cremer N
    Antiviral Res; 2014 Jan; 101():62-7. PubMed ID: 24211331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC.
    Davis CA; Parniak MA; Hughes SH
    Virology; 2011 Oct; 419(2):64-71. PubMed ID: 21907380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism by which a glutamine to leucine substitution at residue 509 in the ribonuclease H domain of HIV-1 reverse transcriptase confers zidovudine resistance.
    Brehm JH; Mellors JW; Sluis-Cremer N
    Biochemistry; 2008 Dec; 47(52):14020-7. PubMed ID: 19067547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
    Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Sep; 76(18):9143-51. PubMed ID: 12186898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subunit-specific mutational analysis of residue N348 in HIV-1 reverse transcriptase.
    Radzio J; Sluis-Cremer N
    Retrovirology; 2011 Aug; 8():69. PubMed ID: 21859446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2001 May; 75(10):4832-42. PubMed ID: 11312355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.
    Yap SH; Sheen CW; Fahey J; Zanin M; Tyssen D; Lima VD; Wynhoven B; Kuiper M; Sluis-Cremer N; Harrigan PR; Tachedjian G
    PLoS Med; 2007 Dec; 4(12):e335. PubMed ID: 18052601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz stimulates HIV-1 reverse transcriptase RNase H activity by a mechanism involving increased substrate binding and secondary cleavage activity.
    Muchiri JM; Li D; Dykes C; Bambara RA
    Biochemistry; 2013 Jul; 52(29):4981-90. PubMed ID: 23806074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
    Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
    Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6.
    Corona A; Meleddu R; Esposito F; Distinto S; Bianco G; Masaoka T; Maccioni E; Menéndez-Arias L; Alcaro S; Le Grice SF; Tramontano E
    PLoS One; 2016; 11(1):e0147225. PubMed ID: 26800261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective interaction of the human immunodeficiency virus type 1 reverse transcriptase nonnucleoside inhibitor efavirenz and its thio-substituted analog with different enzyme-substrate complexes.
    Maga G; Ubiali D; Salvetti R; Pregnolato M; Spadari S
    Antimicrob Agents Chemother; 2000 May; 44(5):1186-94. PubMed ID: 10770750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.
    Miranda LR; Götte M; Liang F; Kuritzkes DR
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2648-56. PubMed ID: 15980332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of template cleavage in reduced excision of chain-terminating nucleotides by human immunodeficiency virus type 1 reverse transcriptase containing the M184V mutation.
    Acosta-Hoyos AJ; Matsuura SE; Meyer PR; Scott WA
    J Virol; 2012 May; 86(9):5122-33. PubMed ID: 22379084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.